Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity.
- 1 July 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 10 (4) , 559-563
- https://doi.org/10.1161/01.atv.10.4.559
Abstract
Oxidized low density lipoprotein (Ox-LDL) is considered to be involved in the atherogenic process. Factors influencing the formation of Ox-LDL are thus of importance. Oxidation of LDL in a cell-free system in the presence of copper ions was significantly increased (up to 60%) by the presence of platelet-conditioned medium, (PCM) obtained from collagen-activated platelets for the duration of the oxidation period. The effect was time- and dose-dependent and was related to hydrogen peroxide and superoxide production, since PCM-induced enhanced LDL oxidation was inhibited by catalase and by superoxide dismutase, but not by protease treatments. PCM also reduced the fluidity of oxidized LDL by 45%. Upon incubation with a J-774 macrophage-like cell line, PCM-treated Ox-LDL enhanced cellular cholesteryl ester synthesis by 47% and lipoprotein degradation by 41%. Thus platelet secretory products appeared to enhance LDL oxidation through the involvement of oxidative agents. The resulting Ox-LDL demonstrated increased atherogenic properties.This publication has 28 references indexed in Scilit:
- Beyond CholesterolNew England Journal of Medicine, 1989
- Platelet activation by oxidatively modified low density lipoproteinsPublished by Elsevier ,1989
- The effect of platelets on macrophage lipoprotein metabolismAtherosclerosis, 1988
- Platelet Lipoprotein InteractionsSeminars in Thrombosis and Hemostasis, 1988
- Role of platelets in cholesteryl ester formation by U-937 cells.Journal of Clinical Investigation, 1988
- New mechanism for foam cell generation in atherosclerotic lesions.Journal of Clinical Investigation, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Platelet secretory products inhibit lipoprotein metabolism in macrophagesNature, 1985
- Effects of fat level, feeding period, and source of fat on lipid fluidity and physical state of rabbit plasma lipoproteinsAtherosclerosis, 1983
- The role of platelets in thrombotic and vascular diseaseProgress in Cardiovascular Diseases, 1979